New Study: 50 Stocks Will Crash While 7 MAGA Stocks Will Soar

If you own any of these stocks -- directly or through mutual funds -- I want to encourage you to sell them before April 30th. I've compiled all 50 companies in my "MAGA Blacklist" report. Your retirement could depend on seeing this list.

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Mortgage lender Rocket Cos. to acquire real estate brokerage Redfin in deal valued at $1.75 billion

Mortgage lender Rocket Cos. has agreed to acquire online real estate brokerage Redfin in an all-stock deal valued at $1.75 billion.

North Carolina Republicans seek to force top Democrats to fall in line with Trump agenda

RALEIGH, N.C. (AP) — North Carolina Republicans who are resolved to promote President Donald Trump’s agenda now seek to compel the recently elected Democratic governor to aid the president's immigration crackdown and stop the new Democratic attorney general from fighting Trump in court.

[Revealed] Trump and Elon's Shocking New Plan for America - Ad

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

AI pioneers who channeled 'hedonistic' machines win computer science's top prize

Teaching machines in the way that animal trainers mold the behavior of dogs or horses has been an important method for developing artificial intelligence and one that was recognized Wednesday with the top computer science award.

Mexican finance minister, a holdover from previous administration, resigns and is replaced by deputy

MEXICO CITY (AP) — Mexican Finance Secretary Rogelio Ramírez de la O, a holdover from the previous administration, resigned Friday for personal reasons and will be replaced by his deputy, President Claudia Sheinbaum said.

Gold's About to Go Parabolic? (Trump's First Term Sent It Soaring) - Ad

During President Trump's first term, tariffs & rate cuts sent gold soaring 57%. Now, Trump is using the same playbook. Are you expecting different results? Hint: Gold is now surging, and experts predict gold could hit $4,000... even $10,000! Move funds from your IRA & 401(k) into gold--TAX & PENALTY-FREE--while you still can!

Mexico to impose retaliatory tariffs on US following China and Canada as trade war heats up

MEXICO CITY (AP) — Mexico President Claudia Sheinbaum said Tuesday that Mexico will respond to with its own retaliatory tariffs on U.S. goods.

Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders

UCB's Bimzelx shows sustained efficacy in psoriasis and hidradenitis suppurativa, with high skin clearance rates and improved symptoms over long-term trials.

Washington Won't Save You--but This 4-Step Plan Might - Ad

America's economy is unraveling--soaring costs, skyrocketing debt, and Wall Street insiders dumping stocks. This isn't a recession--it's an economic breakdown. Stocks could crash 50%, real estate 40%, and inflation will eat your savings. But history shows: the biggest crashes create the biggest fortunes--if you act now!

Canada incoming PM says he'll keep tariffs in place until US shows respect and commits to free trade

TORONTO (AP) — Incoming said Tuesday that his government will keep tariffs in place until Americans show respect and commit to free trade after U.S. President Donald Trump threatened historic financial devastation for Canada.

Are you owed an extra $2,105 a month in extra cash? - Ad

A little-known "loophole" has allowed a handful of regular Americans to legally collect over $109,200,000 in bonus cash. And today's your chance to join them. It doesn't matter how old you are or even how much money you make. And my research shows there's no way you can be denied from taking part in this opportunity.

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip

Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.

Palantir's Head Of Defense Warns Of China's War Preparations: 'We're Not Taking It Seriously'

Palantir Technologies Inc. Head of Defense and former Congressman Mike Gallagher is sounding alarms about China's military intentions, warning that the U.S. is failing to adequately prepare for potential conflict.

Globetrotting CFA Discovers Top Four Gold Miners With 100X Upside Potential - Ad

Most CFAs sit at a desk... But one unusual CFA went all-in on gold investing 20 years ago... and accidentally positioned himself as the expert's expert for the current bull market. Garrett Goggin's research has led him to the the Top Four miners sitting on potential upside of 100X or more for the current gold mania. He's been offered as much as $100k by Hedge Funds.

IPO Momentum Builds In 2025: Diginex, CTRL Group, And Others Post Strong Gains

US IPO activity saw a meaningful recovery in 2024, with 38% more IPOs and 48% higher proceeds. 2025 may bring even more growth as 36 IPOs have already been priced this year, including Diginex's 600% return.

Why United Airlines (UAL) Stock Is Down 15% This Week

United Airlines shares are trading lower by 15% since Monday's open. The stock is down amid rising trade tensions, higher costs and global uncertainty.

Warning: What They Haven't Told You (Yet) About the 2025 Selloffs - Ad

In light of massive recent selloffs... Stansberry Research has issued a new warning for the public. Their latest research shows the real truth about the 2025 tariff selloffs is much bigger -- and much worse -- than the public realizes. They say unless you take the right steps now... You could soon see your wealth cut in half.

Trump is buying a Tesla. A look at the harsh things he's had to say about EVs over the years

WASHINGTON (AP) — President Donald Trump, who's to show loyalty to company CEO , has had plenty to say about electric vehicles over the years. Most of it is not good.

Facing competition from Big Tech, states dangle incentives and loosen laws to attract power plants

HARRISBURG, Pa. (AP) — Facing projections of spiking energy demand, U.S. states are pressing for ways to build new power plants faster as policymakers increasingly worry about protecting their residents and economies from rising electric bills, power outages and other consequences of falling behind Big Tech in a race for electricity.

Claim the "No.1 Coin of 2025" Before March 24th - Ad

After spotting 44 different coins that have returned over 100%...Chris Rowe is now exposing the details behind the "Superpower Coin"... that's partnered with 19 of the largest companies from some of the world's largest superpower nations... A little-known 3-cent coin that is poised to outperform Bitcoin in 2025... starting on March 24th.

Explainer: What's a recession and why is rising anxiety about it roiling markets?

WASHINGTON (AP) — Stock markets , consumers and businesses have started to , and economists are marking down their estimates for growth this year, with some even seeing rising odds of a recession.

Universities are facing big cuts to research funding. At Duke, it's a time for 'damage control'

DURHAM, N.C. (AP) — Facing the potential loss of hundreds of millions of dollars in federal funding, Duke University is preparing for the worst.

The $240M AI Disruptor - Ad

This Nasdaq-listed company is redefining AI in the $124 billion smart glass market. From cockpit shading systems to energy-efficient building glass, their technology powers global leaders like Boeing, Mercedes-Benz, and National Geographic. Their projected $240M revenue from aerospace positions them as an AI-driven market disruptor you can't ignore.

US inflation may have slowed slightly last month but tariffs threaten reversal

WASHINGTON (AP) — U.S. inflation may have cooled a bit last month but it could be a short reprieve as President Donald Trump's are widely expected to keep prices elevated in the coming months.

Freshpet Is Not Out Of The Woods On Consumption Trends, Analyst Says

JP Morgan analyst cuts Freshpet price forecast to $102 while maintaining a Neutral rating. Concerns over changing consumption trends and accuracy of estimates, but strong revenue growth and long-term potential. EBITDA and revenue growth estimates revised.

The $20 Trillion Secret of Room 3330 - Ad

Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].

Warning: China Launches AI Attack on America - Ad

China just launched what can only be described as an AI attack on America. And according to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... President Trump is already planning a counter attack. And it's creating an incredible opportunity for you in this small group of AI stocks.

Microsoft Dodges UK Competition Crackdown Over OpenAI Deal, Watchdog Director Says Partnership Doesn't Get 'A Clean Bill Of Health'

Microsoft's $13 billion investment in OpenAI has escaped a formal merger investigation by the U.K.'s Competition and Markets Authority (CMA), but regulators warn that the partnership still raises potential competition concerns.

Which US companies are pulling back on diversity initiatives?

A growing number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that endorsed following the protests that accompanied the Minneapolis police killing of George Floyd, a Black man, in 2020.

Warren Buffett's Investing Partner's Shocking Final Move - Ad

Before he passed away, Charlie Munger, Warren Buffett's investing partner of 60 years, was rumored to have quietly made one final investment... Up until now, it has remained hidden from the public. It's potentially the smartest, most profitable, and most under-valued AI investment you can make today.

Trump's Crypto Reserve Plan Sparks Controversy, Schiff Questions XRP Inclusion, Polymarket CEO Invited To White House: This Week In Crypto

The crypto world was shaken as Trump's announcement of a U.S. cryptocurrency reserve sparked backlash from tech allies, criticism from economist Peter Schiff, and calls for a Congressional investigation into potential insider trading and market manipulation.

AT&T Confirms 2025 Targets, Cash Flow Strength And Debt Reduction Plan: Details

AT&T reaffirms 2025 financial targets, plans to execute long-term strategic plan. Expects strong first quarter of 2025, maintains dividend.

Elon's Biggest Secret Could Save Your Retirement - Ad

From a near-fatal car crash to surviving deadly malaria, Musk's fearless drive built Tesla, SpaceX, and Starlink. Now, he's warning America--and smart investors are listening. Discover the Trump IRS Loophole to protect your IRA & 401(k).

3 ETFs With Super Micro Computers Exposure, Enjoy AI Surge

Super Micro (NASDAQ: SMCI) is a top player in AI infrastructure with growing demand and potential for investors. ETFs like SMH, BOTZ and IGV can benefit from its growth.

March 20th: The NEXT 50X Nvidia Call - Ad

In 2016 Louis Navellier made a big prediction regarding Nvidia's GPUs... Its stock price was a split-adjusted $1 and went up more than 7,000% at its peak. Don't miss Louis NEXT BIG Nvidia call. (Plus 6 stocks you need to own before March 20th.)

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service